Incyte (INCY) Gross Margin (2010 - 2026)

Incyte (INCY) reported Gross Margin of 91.79% for Q1 2026, down 126.0% on a YoY basis from 353.03% in Q1 2025, and little changed quarter-over-quarter from 91.96% in Q4 2025.

Incyte (INCY) Gross Margin (2010 - 2026) Analysis & Trends

Incyte has reported Gross Margin for 17 years, with the latest figure at 91.79% in Q1 2026.

  • For the quarter ending Q1 2026, Gross Margin fell 126.0% year-over-year to 91.79%; the trailing twelve-month figure through Mar 2026 stood at 92.47% (down 18.0% YoY), and the FY2025 full-year result was 92.76%, up 12.0% from the prior year.
  • Gross Margin for Q1 2026 stood at 91.79%, roughly flat from 91.96% in the prior quarter.
  • The five-year high for Gross Margin was 94.44% in Q2 2022, with the low at 91.79% in Q1 2026.
  • Historically, Gross Margin has averaged 93.04% across 5 years, with a median of 93.05% in 2025.
  • Annual changes were most pronounced in 2022 — Gross Margin plunged 173 bps — and 2025, when it soared 86 bps.
  • Incyte's Gross Margin stood at 93.62% in 2022, then declined by 1 bps to 93.12% in 2023, then retreated by 1 bps to 92.49% in 2024, then slipped by 1 bps to 91.96% in 2025, then retreated by 0 bps to 91.79% in 2026.
  • The last three Gross Margin figures came in at 91.79% (Q1 2026), 91.96% (Q4 2025), and 92.75% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 79.04%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 86.85%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Incyte 19.62 Bn 15.60 Bn 1.17 Bn 91.79%

Historic Data

Download Data
DateValue
Mar 31, 2026 91.79%
Dec 31, 2025 91.96%
Sep 30, 2025 92.75%
Jun 30, 2025 93.52%
Mar 31, 2025 93.05%
Dec 31, 2024 92.49%
Sep 30, 2024 92.44%
Jun 30, 2024 92.66%
Mar 31, 2024 93.08%
Dec 31, 2023 93.12%
Sep 30, 2023 93.46%
Jun 30, 2023 92.84%
Mar 31, 2023 92.97%
Dec 31, 2022 93.62%
Sep 30, 2022 93.37%
Jun 30, 2022 94.44%
Mar 31, 2022 94.19%
Dec 31, 2021 94.92%
Sep 30, 2021 95.10%
Jun 30, 2021 94.61%